Medicare's Ozempic and Wegovy price in 2027: $274 for 30 days
By John Samaras, price analyst · Prices checked Nov 16, 2026
From January 1, 2027, Medicare's negotiated price for Ozempic, Rybelsus and Wegovy is $274 for a 30-day supply. CMS puts the 2024 list price at $959, so the negotiated price is 71% lower. It is the price of the drug in Part D, not your copay.
What it costs without insurance
If Medicare won't cover it for weight loss
Eden$99 a monthIncludes medication, provider review and shippingCheck price →
Collective$59 a month, drug priceLowest price on our chartCheck price →
Who this affects
People with a standalone Part D plan or a Medicare Advantage drug plan who take Ozempic, Rybelsus or Wegovy for a use Part D covers, such as type 2 diabetes or cardiovascular disease. CMS counted 2,282,000 Part D enrollees who used these drugs in 2024. Part D still does not cover Wegovy for weight loss alone.
When it starts
CMS says the negotiated prices take effect on January 1, 2027.
If you lose coverage: cash now
Two cash programs to check.
No insurance needed.
Prices checked Nov 16, 2026.
- Eden$99 a monthIncludes medication, provider review and shippingcompounded semaglutidecompounded tirzepatide $129 a monthCheck price →Eden's GLP-1 page, then an online assessment
- Check price →
- Compounded semaglutide and tirzepatide prices, from $59 a month
- Find your GLP-1 program in four questions
What the CMS fact sheet says
Medicare prescription drug plans, including standalone Part D plans and Medicare Advantage-prescription drug plans, must include in their formularies the selected drugs
- Per package, CMS lists $276.78 for one Ozempic 4 mg/3 mL pen, $276.78 for 30 Rybelsus 7 mg tablets and $385.63 for four Wegovy 2.4 mg pens.
- Ozempic, Rybelsus and Wegovy are one selected drug in the program because all three are Novo Nordisk's semaglutide.
- Every Medicare drug plan has to carry these drugs on its formulary from that date.
- CMS says the price applies for as long as the drug stays in the negotiation program, with yearly inflation updates.
Sources:
- CMS, Medicare Drug Price Negotiation Program: Negotiated Prices for Initial Price Applicability Year 2027, dated November 2025, read November 15, 2026.
- CMS, Medicare GLP-1 Bridge: information for Part D plans, dated August 6, 2026, read November 15, 2026.
What to do before January 1
- Look up where Ozempic, Rybelsus or Wegovy sits on your 2027 plan's drug list. Coinsurance is a share of a price, so it can fall with the price.
- For weight loss alone, check the Medicare GLP-1 Bridge instead.
- If neither works, compare the cash routes on this page.
The Medicare GLP-1 Bridge in 2027. Medicare Advantage open enrollment for 2027. Novo's $675 list price from January 1.
What cash costs today
Compounded semaglutide and tirzepatide are pharmacy-made versions that are not Wegovy, Ozempic, Zepbound or Mounjaro.
Compounded prices are the monthly drug price at the lowest-priced program. Any membership is listed on that program's own page.
| Cash route | Monthly price | Checked |
|---|---|---|
| Compounded semaglutide | From $59 | November 16, 2026 |
| Compounded tirzepatide | From $69 | November 16, 2026 |
| Wegovy pill from NovoCare | From $149 at the 1.5mg starter dose | November 16, 2026 |
| Zepbound vial from LillyDirect | From $299 at 2.5mg | November 16, 2026 |
Buying cash in late November? GLP-1 Black Friday and Cyber Monday offers shows each program's 30-day low and high.
Frequently asked questions
Will I pay $274 for Ozempic on Medicare in 2027?
Does the negotiated price mean Medicare covers Wegovy for weight loss?
How much lower is the Medicare price than the list price?
Cash does not go through your plan and does not count toward its deductible. Federal plan GLP-1 changes for 2027. GLP-1 coverage by payer.